← Evidence map

ArticleFrontiers in immunology2026

Translational development and first-in-human compassionate infusion of NK-92 cells expressing a CD5-based chimeric antigen receptor (SRCD5CAR-NK-92) in a patient with multidrug-resistant fusariosis.

María Velasco-de-Andrés et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Translational development and first-in-human compassionate infusion of NK-92 cells expressing a CD5-based chimeric antigen receptor (SRCD5CAR-NK-92) in a patient with multidrug-resistant fusariosis. | OpenQuestion